TELA Bio Inc (NAS:TELA)
$ 3.03 0 (0%) Market Cap: 119.35 Mil Enterprise Value: 143.57 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q4 2019 TELA Bio Inc Earnings Call Transcript

Mar 27, 2020 / 12:00PM GMT
Release Date Price: $8.01 (+0.12%)
Operator

Good morning, ladies and gentlemen, and welcome to the TELA Bio Fourth Quarter and Full Year 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to Stuart Henderson, Vice President, Corporate Development and Investor Relations for TELA Bio. Please go ahead, sir.

Stuart M. Henderson
TELA Bio, Inc. - VP of Corporate Development & IR

Thank you, Sonya, and good morning, everyone.

Earlier today, TELA Bio released financial results for the quarter and year ended December 31, 2019. A copy of the press release is available on the company's website.

Joining me on today's call are Tony Koblish, President and CEO; and Nora Brennan, CFO. Tony will begin the call by providing an overview of our operational highlights, and then Nora will provide a detailed analysis of our fourth quarter and full year financial performance later in the call.

Before we begin, I'd like to remind you that during this conference call, the company will make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot